Aslan Fred 4
4 · Artiva Biotherapeutics, Inc. · Filed Jul 22, 2024
Insider Transaction Report
Form 4
Aslan Fred
DirectorPresident and CEO
Transactions
- Award
Common Stock
2024-07-22+228,905→ 228,905 total - Award
Employee Stock Option (Right to Buy)
2024-07-18+343,811→ 343,811 totalExercise: $12.00Exp: 2034-07-17→ Common Stock (343,811 underlying)
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.
- [F2]25% of the shares will vest on July 19, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.